TerminatedNCT05193318
KAP for Depression in Abstinent Opioid Users
Medication studyAges 18–64United States
Understand this study
Who could participate?
Listed age limits: 18 years to 64 years.
- Listed locations
- CharlestonSee all locations and recruitment
- Study phase
- Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.
What to know before participating
A point to clarify
This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?
Things to check before joining
Study start dateStarted: January 13, 2022
- Recruitment status
- Terminated
- Enrollment listed in the registry
- 5
- Sponsor
- Medical University of South Carolina
- Sponsor type
- University
- Study type
- Drug
- Intervention type
- Drug
- Study phase
- Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.
- Locations
- United States
- Age range
- From 18 Years to 64 Years
- Official registry ID
- NCT05193318
- Official title
Show the full official title
Ketamine-assisted Psychotherapy for the Treatment of Persistent Depression in Abstinent Opioid Users
Recruitment & locations
TerminatedThis badge reflects the study status reported by the registry. Check the registry for the latest information.
Charleston
Interested in joining this study?
Questions about this study
Who is behind this study?
The study sponsor is Medical University of South Carolina, a university.
Does this study involve medication?
Yes. The study involves medication, including Ketamine-assisted psychotherapy.
Who can participate?
Listed age limits: 18 years to 64 years.
Is this study still recruiting?
The registry lists this study as terminated.
